Proteoliposomes to protect and transport nutrients beneficial to health.

Why is this project innovative? The key innovation lies in the development of plant-derived proteoliposomes enriched with aquaporins, something little explored in the nutraceutical field. Unlike traditional liposomes (which are unstable), the proposed proteoliposomes improve stability and functionality under different conditions (pH, temperature), which is a significant technological advance. Furthermore, these systems have been shown to allow for slower and more efficient absorption of bioactive compounds, increasing their bioavailability and, therefore, their positive impact on health. This provides scientific support for nutritional claims, which aligns perfectly with European regulations. Compared to synthetic or animal-based technologies, this proposal is based on plant sources, responding to the growing demand for more natural, clean, and sustainable solutions in the food and supplement markets

Why would it help a company differentiate itself and sell more? Incorporating these proteoliposomes would allow the company to launch functional products with proven efficacy, making it easier to comply with stringent European regulations for health claims, thus gaining consumer trust. Current solutions (such as conventional liposomes or generic microencapsulated products) present stability or efficacy issues. This technology would make it possible to offer supplements and functional foods with improved performance, which is a very powerful selling point. Consumers are increasingly seeking sustainable, plant-based ingredients with specific health benefits, and this technology addresses all these requirements simultaneously. This allows the company to position itself as a leader in green innovation and holistic health. Products based on this technology could be targeted at the high-end segment, where innovation, efficacy, and technological traceability are more valued, thereby increasing profit margins.